Dr. Luciano D’Adamio, obtained his MD from the University of Perugia, Italy. Working on his thesis project at the Dana Farber Cancer Institute, Harvard Medical School, he obtained his PhD from Sapienza University of Rome, Italy.  In 1996, as an intramural principal investigator at the National Institutes of Health, his lab was the first to identify the role of cell death pathways in Alzheimer's disease, starting his interest in neurodegeneration. In 2000, he joined the Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University as an Associate Professor and was promoted to Professor with tenure in 2004. He was recruited to Rutgers from Albert Einstein College of Medicine in June 2017.

Dr. D’Adamio is one of the world’s leading expert in the field of Alzheimer’s disease research. During the last 15 years, his lab has used genetic approaches to dissect the mechanisms of age-related neurodegeneration occurring in Alzheimer disease, Familial British dementia and Danish dementia. He has published more than 97 peer-reviewed articles in high impact journals such as Science, Cell, Neuron, PNAS etc. His papers have been cited more than 7500 times with an H-index of 46. His contribution to the field of Alzheimer’s disease has been recognized by the 2001 Alzheimer Award from the Journal of Alzheimer's Disease and the 2011 Zenith Award from Alzheimer’s Association. He has also received numerous awards from the Alzheimer’s Association, the Irene Diamond Foundation, Edward N. and Della L. Thome Memorial Foundation.

Dr. D’Adamio research has been continuously funded by the National Institutes of Health and other funding agencies since 2000, receiving more than $13.5 million from NIH to support his research program. He is currently the Principal Investigator on multiple grant awards from the National Institute of Aging at NIH.  He holds five patents on his discoveries and is the scientific co-founder of three companies- RemeGenix, Inc, Kappa Life Sciences and SienaGen, s.r.l.

Dr. D’Adamio is a member of the editorial board of Current Alzheimer Research and Molecular Neurodegeneration, both of which are major journals in the field of Alzheimer’s disease and neurodegeneration. He has served on numerous national and international grant review committees and has mentored and trained over 20 student and post-doctoral scientists. As the Herbert C. and Jacqueline Krieger Klein Endowed Chair in Alzheimer’s disease and Neurodegeneration Research, Dr. D’Adamio spearheads basic and translational research into Alzheimer’s disease and neurodegeneration at Rutgers.

Dr. D'Adamio's Lab at Rutgers-New Jersey Medical School